2,208 results match your criteria: "Lymphangiectasia"
Expert Opin Biol Ther
December 2024
Division of Allergy and Immunology, Department of Pediatrics, School of Medicine, Marmara University, Istanbul, Turkey.
Introduction: CHAPLE disease is a severe, ultra-rare disorder caused by CD55 gene mutations, leading to uncontrolled complement hyperactivation, protein-losing enteropathy, and systemic thrombosis. Recent advances in targeted therapies, particularly the C5 inhibitor pozelimab (Veopoz), offer new treatment options by addressing complement dysregulation, marking a shift from symptomatic to precision therapy.
Areas Covered: This review explores the pathophysiology, clinical manifestations, and current treatments for CHAPLE disease.
J Oral Maxillofac Pathol
October 2024
Department of Oral Pathology, Saveetha Dental College and Hospitals, Saveetha Institute of Medical and Technical Sciences, Saveetha University, Chennai, Tamil Nadu, India.
Pak J Med Sci
December 2024
Selim Demirci, Department of Gastroenterology, Dr. Abdurrahman Yurtaslan Oncology Training and Research Hospital, Ankara, Turkey.
Zhonghua Wai Ke Za Zhi
December 2024
Department of Lymphatic Surgery, Beijing Shijitan Hospital, Capital Medical University, Beijing100038, China.
Respir Res
November 2024
Center for Pulmonary Medicine, Department of Pneumology, Mainz University Medical Center, Mainz, Germany.
Arterioscler Thromb Vasc Biol
November 2024
Northwestern University Feinberg School of Medicine, Chicago, IL.
Background: Lymphangiogenesis is believed to be a protective response in the setting of multiple forms of kidney injury and mitigates the progression of interstitial fibrosis. To augment this protective response, promoting kidney lymphangiogenesis is being investigated as a potential treatment to slow the progression of kidney disease. As injury-related lymphangiogenesis is driven by signaling from the receptor VEGFR3 (vascular endothelial growth factor receptor 3) in response to the cognate growth factor VEGF (vascular endothelial growth factor)-C released by tubular epithelial cells, this signaling pathway is a candidate for future kidney therapeutics.
View Article and Find Full Text PDFAnimals (Basel)
October 2024
Department of Veterinary Medicine and Animal Sciences, University of Milan, Via dell'Università 6, 26900 Lodi, Italy.
Front Med (Lausanne)
October 2024
Department of Gastroenterology, Ministry of Education Key Laboratory of Child Development and Disorders, China International Science and Technology Cooperation Base of Child Development and Critical Disorders, Chongqing Key Laboratory of Pediatrics, National Clinical Research Center for Child Health and Disorders, Children's Hospital of Chongqing Medical University, Chongqing, China.
Pathology
September 2024
Department of Gastroenterology, Zhongnan Hospital of Wuhan University, China. Electronic address:
Zhonghua Fu Chan Ke Za Zhi
October 2024
Department of Lymph Surgery, Capital Medical University Affiliated Beijing Shijitan Hospital, Beijing 100038, China.
Rev Esp Enferm Dig
October 2024
Gastroenterology, Unidade Local de Saúde do Alto Ave, Portugal.
Microsurgery
October 2024
Department of Hand and Plastic Surgery, Luzerner Kantonsspital, Lucerne, Switzerland.
Rev Esp Patol
October 2024
Servicio de Anatomía Patológica, Hospital Universitari i Politècnic La Fe, València, Spain.
Int J Surg Pathol
October 2024
PathologyOutlines.com Owner and Founder.
Rev Med Interne
October 2024
Unité de lymphologie, Centre national de référence des maladies vasculaires rares (lymphœdème primaire), hôpital Cognacq-Jay, 15, rue Eugène-Millon, 75015 Paris, France. Electronic address:
J Clin Med
August 2024
Gastroenterology Unit, National Institute of Gastroenterology-IRCCS "Saverio de Bellis", 70013 Castellana Grotte, Italy.
J Small Anim Pract
September 2024
Department of Veterinary Medical Sciences, University of Bologna, Bologna, Italy.
Cureus
August 2024
Geriatrics, Beni Suef Hospital, Beni Suef, EGY.
Primary intestinal lymphangiectasia (PIL) is a rare disorder characterized by dilated lymphatic vessels in the gastrointestinal tract, leading to protein-losing enteropathy (PLE). We report the case of a 43-year-old male presenting with refractory PLE, characterized by generalized edema, chronic diarrhea, and significant weight loss over four months. Despite multiple consultations and treatments for presumed inflammatory bowel disease, his symptoms persisted, and his condition worsened.
View Article and Find Full Text PDFJ Aquat Anim Health
September 2024
Smithsonian National Zoological Park, Washington, D.C., USA.
Invest Radiol
January 2025
From the Department of Radiology, Seoul National University Hospital, Seoul, Republic of Korea (S.L., S.H., Y.H.C., J.-Y.H., J.-E.C.); Department of Radiology, Seoul National University College of Medicine, Seoul, Republic of Korea (S.L., S.H., Y.H.C., J.-Y.H., J.-E.C.); and Institute of Radiation Medicine, Seoul National University Medical Research Center, Seoul, Republic of Korea (J.-E.C.).
Congenital lymphatic flow disorders collectively refer to a heterogeneous group of diseases that manifest as chylothorax, chylous ascites, intestinal lymphangiectasia, protein-losing enteropathy, and peripheral extremity or genital lymphedema, all in the absence of identifiable injury to the lymphatic system. We have only recently begun to understand congenital lymphatic flow disorders through the ability to image lymph flow dynamically. Intranodal dynamic contrast-enhanced magnetic resonance lymphangiography (DCMRL) is a crucial technique for imaging lymphatic flow in pediatric patients with congenital lymphatic flow disorders.
View Article and Find Full Text PDFPediatr Neonatol
November 2024
Unidade de Gastroenterologia Pediátrica, Serviço de Pediatria, ULS São João, Portugal.
Gastrointest Endosc
December 2024
Department of Hepatology, Indian Institute of Liver and Digestive Sciences, Kolkata, India.
Expert Opin Pharmacother
August 2024
Division of Allergy and Immunology, Department of Pediatrics, School of Medicine, Marmara University, Istanbul, Turkey.
J Am Vet Med Assoc
October 2024
5School of Veterinary Medicine, Texas Tech University, Amarillo, TX.